These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31483473)

  • 1. Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications.
    Desai RJ; Good MM; San-Juan-Rodriguez A; Henriksen A; Cunningham F; Hernandez I; Good CB
    JAMA Netw Open; 2019 Sep; 2(9):e1910626. PubMed ID: 31483473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Incident Varenicline Prescribing Among Veterans Following the US Food and Drug Administration Drug Safety Warnings.
    Gerlach LB; Van T; Kim HM; Chang MM; Bohnert KM; Zivin K
    J Clin Psychiatry; 2021 Dec; 83(1):. PubMed ID: 34936245
    [No Abstract]   [Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric safety of varenicline in the general and COPD population with and without psychiatric disorders: a retrospective cohort study in a real-world setting.
    Wang Y; Bos JH; Schuiling-Veninga CCM; Boezen HM; van Boven JFM; Wilffert B; Hak E
    BMJ Open; 2021 May; 11(5):e042417. PubMed ID: 34035088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patch.
    Cunningham FE; Hur K; Dong D; Miller DR; Zhang R; Wei X; McCarren M; Mosholder AD; Graham DJ; Aspinall SL; Good CB
    Addiction; 2016 Jul; 111(7):1283-92. PubMed ID: 26826702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Use of Medications for Smoking Cessation in Medicare, 2007-2012.
    Jarlenski M; Hyon Baik S; Zhang Y
    Am J Prev Med; 2016 Sep; 51(3):301-8. PubMed ID: 27036506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Food and Drug Administration and varenicline: should risk communication be improved?
    Davies NM; Thomas KH
    Addiction; 2017 Apr; 112(4):555-558. PubMed ID: 27558015
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.
    Meyer TE; Taylor LG; Xie S; Graham DJ; Mosholder AD; Williams JR; Moeny D; Ouellet-Hellstrom RP; Coster TS
    Addiction; 2013 Jan; 108(1):203-10. PubMed ID: 22812921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline as a Cause of Suicidal Outcomes.
    Hughes JR
    Nicotine Tob Res; 2016 Jan; 18(1):2-9. PubMed ID: 25572451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and Neuropsychiatric Events after Varenicline Use for Smoking Cessation.
    Gershon AS; Campitelli MA; Hawken S; Victor C; Sproule BA; Kurdyak P; Selby P
    Am J Respir Crit Care Med; 2018 Apr; 197(7):913-922. PubMed ID: 29260881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
    Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Televised Direct-to-Consumer Advertising for Varenicline on Prescription Dispensing in the United States, 2006-2009.
    Kim Y; Kornfield R; Shi Y; Vera L; Daubresse M; Alexander GC; Emery S
    Nicotine Tob Res; 2016 May; 18(5):1180-7. PubMed ID: 26385926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental health status of varenicline and bupropion users during a quit attempt compared to current smokers, other quitters, and non-smokers.
    Shewale AR; Borse MS; Brown JD; Li C
    Drug Alcohol Depend; 2015 Sep; 154():132-8. PubMed ID: 26169448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation-recent advances.
    McNeil JJ; Piccenna L; Ioannides-Demos LL
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):359-67. PubMed ID: 20602163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.